checkAd

     102  0 Kommentare Lantern Pharma to Present at Upcoming Investor Conferences - Seite 2


    The Lantern Pharma Stock at the time of publication of the news with a raise of +3,60 % to 4,89USD on Nasdaq stock exchange (05. Oktober 2022, 02:00 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors

    Seite 2 von 2

    Lantern Pharma to Present at Upcoming Investor Conferences - Seite 2 Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") and machine learning (“M.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery …